Michael Dunn Reflects on all ASH25 Represents for the Bleeding Disorders Community
Michael Dunn, Vice President – Head of Rare Disease Portfolio at Genentech, shared on LinkedIn:
”I’m pausing to take a moment to reflect on all ASH25 represents for the bleeding disorders community – innovation, hope, progress.
I feel energized to be here.
Connecting with brilliant minds, learning about the latest advancements in hematology, and sharing how Genentech is advancing the standard of care for patients and their families.
I’m proud to be part of an organization that prioritizes standing alongside the hemophilia A community.
Every step forward is driven by our commitment to push the boundaries of what’s possible and deliver meaningful progress for people living with bleeding disorders.
A big thank you to the local Florida team for their above and beyond efforts at the booth Jeremy V., Lucila Ramirez Donaldson, William Lopez and to members of the leadership team who were representing our collective efforts for those with bleeding disorders Erik Lundgren, Tony Lin, Juliana Lagrasta Biondo, Gina Noh”
All from ASH25 featured in Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?